OJRad  Vol.4 No.2 , June 2014
Revisiting Imaging and Pathology of Malignant Appearing Uterine Smooth Muscle Tumors: A Mistaken Identity of Leiomyosarcoma on MRI
Abstract: Uterine leiomyoma is a relatively common condition occurring in a majority of African American and Caucasian women by age 50. Magnetic resonance imaging of the pelvis with contrast is the modality of choice when evaluating uterine tumors. We report a case of a patient with a four-day history of intra-menstrual vaginal bleeding who underwent magnetic resonance imaging of the pelvis that suggested the tumor was a leiomyosarcoma, the malignant counterpart of leiomyoma. Therefore, the patient underwent pre-operative uterine artery embolization to decrease blood loss with exploratory laparotomy, resection of pelvic mass and dilation and curettage. Pathologic evaluation of the mass returned a diagnosis of leiomyoma. Magnetic resonance imaging evaluation of leiomyomata remains difficult. Further development of imaging parameters could improve diagnosis of benign uterine fibroids.
Cite this paper: Juhl, M. , Knuttinen, M. , Kothari, R. and Groth, J. (2014) Revisiting Imaging and Pathology of Malignant Appearing Uterine Smooth Muscle Tumors: A Mistaken Identity of Leiomyosarcoma on MRI. Open Journal of Radiology, 4, 177-181. doi: 10.4236/ojrad.2014.42023.

[1]   Baird, D.D., Dunson, D.B., Hill, M.C., Cousins, D. and Schectman, J.M. (2003) High Cumulative Incidence of Uterine Leiomyoma in Black and White Women: Ultrasound Evidence. American Journal of Obstetrics & Gynecology, 188, 100-107.

[2]   Bell, S.W., Kempson, R.L. and Hendrickson, M.R. (1994) Problematic Uterine Smooth Muscle Neoplasms. A Clinicopathologic Study of 213 Cases. The American Journal of Surgical Pathology, 18, 535-558.

[3]   Tavassoli, F.A. and Devilee, P. (2003) World Helath Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. 3rd Edition, IARC Press, 233-242.

[4]   Dinh, T.A., Oliva, E.A., Fuller Jr., A.F., Lee, H. and Goodman, A. (2004) The Treatment of Uterine Leiomyosarcoma. Results from a 10-Year Experience (1990-1999) at the Massachusetts General Hospital. Gynecologic Oncology, 92, 648-652.

[5]   Tanaka, Y.O., Nishida, M., Tsunoda, H., Okamoto, Y. and Yoshikawa, H. (2004) Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcomas of the Uterus: MR Findings. Journal of Magnetic Resonance Imaging, 20, 998-1007.

[6]   Rha, S.E., Byun, J.Y., Jung, S.E., Lee, S.L., Cho, S.M., Hwang, S.S., Lee, H.G., Namkoong, S.-E. and Lee, J.M. (2003) CT and MRI of Uterine Sarcomas and Their Mimickers. AJR, 181, 1369-1374.

[7]   Sahdev, A., Sohaib, S.A., Jacobs, I., Shepherd, J.H., Oram, D.H. and Reznek, R.H. (2001) MR Imaging of Uterine Sarcomas. AJR, 177, 1307-1311.

[8]   Cornfeld, D., Israel, G., Marel, M., Weinreb, J., Schwartz, P. and McCarthy, S. (2010) MRI Appearance of Mesenchymal Tumor s of the Uterus. EJR, 74, 241-249.

[9]   Sato, K., Yuasa, N., Fujita, M. and Fukushima, Y. (2014) Clinical Application of Diffusion-Weighted Imaging for Preoperative Differentiation between Uterine Leiomyoma and Leiomyosarcoma. American Journal of Obstetrics & Gynecology, 210, 368.e1-8.

[10]   Avritscher, R., Iyer, R.B., Ro, J. and Whitman, G. (2001) Lipoleiomyoma of the Uterus. AJR, 177, 856.